STERIS (STE) Financials

$226.69 +0.20 (+0.09%)

Closing price 08/1/2025 03:59 PM Eastern

Extended Trading

$226.51 -0.18 (-0.08%)

As of 08/1/2025 04:13 PM Eastern

Annual Income Statements for STERIS

This table shows STERIS's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	3/31/2017	3/31/2018	3/31/2019	3/31/2020	3/31/2021	3/31/2022	3/31/2023	3/31/2024
Net Income / (Loss) Attributable to Common Shareholders	110	291	304	408	397	244	107	378
Consolidated Net Income / (Loss)	111	292	305	408	397	243	106	380
Net Income / (Loss) Continuing Operations	111	292	305	408	397	284	556	553
Total Pre-Tax Income	185	355	369	499	518	367	680	703
Total Operating Income	226	400	411	537	548	478	791	836
Total Gross Profit	1,026	1,093	1,175	1,320	1,343	1,883	1,981	2,218
Total Revenue	2,613	2,620	2,782	3,031	3,108	4,223	4,536	5,139
Operating Revenue	2,613	2,620	2,782	3,031	3,108	4,223	4,536	5,139
Total Cost of Revenue	1,587	1,527	1,607	1,711	1,764	2,340	2,556	2,921
Operating Cost of Revenue	1,587	1,527	1,607	1,711	1,764	2,340	2,556	2,921
Total Operating Expenses	800	693	764	783	795	1,405	1,190	1,382
Selling, General & Admin Expense	682	632	670	717	731	1,318	1,091	1,252
Research & Development Expense	59	61	63	66	66	87	98	104
Restructuring Charge	0.22	0.10	31	0.67	-2.91	0.05	0.49	26
Total Other Income / (Expense), net	-42	-45	-42	-38	-31	-111	-111	-133
Interest Expense	45	51	45	40	37	89	108	144
Other Income / (Expense), net	2.96	5.73	3.02	1.99	6.35	-22	-2.88	11
Income Tax Expense	74	63	64	91	121	82	124	150
Net Income / (Loss) Discontinued Operations	-	-	-	-	-	-42	-450	-173
Net Income / (Loss) Attributable to Noncontrolling Interest	0.67	0.71	1.03	0.20	-0.53	-1.02	-1.22	1.84
Basic Earnings per Share	$1.29	$3.42	$3.59	$4.81	$4.66	$2.50	$1.07	$3.83
Weighted Average Basic Shares Outstanding	-	-	84.54M	84.92M	170.74M	200.16M	197.30M	197.80M
Diluted Earnings per Share	$1.28	$3.39	$3.55	$4.76	$4.63	$2.48	$1.07	$3.81
Weighted Average Diluted Shares Outstanding	-	-	84.54M	84.92M	170.74M	200.16M	197.30M	197.80M
Weighted Average Basic & Diluted Shares Outstanding	-	-	84.54M	84.92M	170.74M	200.16M	197.30M	197.80M
Cash Dividends to Common per Share	$1.09	$1.21	$1.33	$1.45	$1.57	$1.69	$1.84	$2.03

This table shows STERIS's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	6/30/2022	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	111	-315	124	187	124	115	141	-1.38	145	150	174
Consolidated Net Income / (Loss)	111	-315	123	187	124	116	141	-1.00	146	151	173
Net Income / (Loss) Continuing Operations	111	-315	123	637	131	121	149	172	140	151	173
Total Pre-Tax Income	135	-333	160	718	167	156	190	215	175	195	229
Total Operating Income	158	-306	191	748	198	192	226	245	186	220	245
Total Gross Profit	518	532	521	409	529	546	560	449	572	579	610
Total Revenue	1,156	1,201	1,216	963	1,183	1,238	1,298	1,116	1,280	1,329	1,371
Operating Revenue	1,156	1,201	1,216	963	1,183	1,238	1,298	1,116	1,280	1,329	1,371
Total Cost of Revenue	639	668	694	554	654	692	738	668	707	750	760
Operating Cost of Revenue	639	668	694	554	654	692	738	668	707	750	760
Total Operating Expenses	359	839	331	-339	331	355	334	203	387	359	365
Selling, General & Admin Expense	335	323	305	128	307	328	308	152	336	329	335
Research & Development Expense	25	25	26	23	25	26	25	25	26	27	27
Restructuring Charge	0.03	0.06	0.04	0.36	0.02	-0.02	0.01	26	26	2.80	2.23
Total Other Income / (Expense), net	-23	-27	-30	-30	-31	-36	-37	-30	-10	-25	-17
Interest Expense	23	26	29	31	32	37	39	36	30	20	19
Other Income / (Expense), net	-0.77	-0.52	-1.91	0.32	1.38	1.24	2.08	6.33	20	-5.11	2.55
Income Tax Expense	24	-18	37	81	36	35	41	43	35	44	55
Net Income / (Loss) Discontinued Operations	-	-	-	-	-6.79	-4.45	-7.66	-	5.59	-0.21	-0.08
Net Income / (Loss) Attributable to Noncontrolling Interest	-0.51	0.05	-0.50	-0.26	0.24	1.03	0.20	0.38	0.14	1.14	-0.25
Basic Earnings per Share	$1.11	($3.15)	$1.24	$1.87	$1.25	$1.17	$1.42	($0.01)	$1.47	$1.52	$1.76
Weighted Average Basic Shares Outstanding	200.03M	199.65M	198.57M	197.30M	197.56M	197.60M	197.63M	197.80M	197.23M	98.71M	98.25M
Diluted Earnings per Share	$1.10	($3.15)	$1.24	$1.88	$1.25	$1.16	$1.42	($0.02)	$1.46	$1.51	$1.75
Weighted Average Diluted Shares Outstanding	200.03M	199.65M	198.57M	197.30M	197.56M	197.60M	197.63M	197.80M	197.23M	98.71M	98.25M
Weighted Average Basic & Diluted Shares Outstanding	200.03M	199.65M	198.57M	197.30M	197.56M	197.60M	197.63M	197.80M	197.23M	98.71M	98.25M
Cash Dividends to Common per Share	$0.43	$0.47	$0.47	$0.47	$0.47	$0.52	$0.52	$0.52	$0.52	$0.57	$0.57

This table details how cash moves in and out of STERIS's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	3/31/2017	3/31/2018	3/31/2019	3/31/2020	3/31/2021	3/31/2022	3/31/2023	3/31/2024
Net Change in Cash & Equivalents	34	-81	19	99	-99	128	-140	-1.34
Net Cash From Operating Activities	424	458	540	591	690	685	757	973
Net Cash From Continuing Operating Activities	424	458	540	591	690	685	750	973
Net Income / (Loss) Continuing Operations	111	292	305	408	397	243	106	380
Consolidated Net Income / (Loss)	111	292	305	408	397	243	106	380
Depreciation Expense	188	178	226	197	219	553	553	565
Amortization Expense	-	-	-	0.00	0.00	67	-	4.82
Non-Cash Adjustments To Reconcile Net Income	151	72	5.12	26	50	78	527	301
Changes in Operating Assets and Liabilities, net	-26	-84	3.72	-40	23	-256	-436	-277
Net Cash From Investing Activities	-104	-204	-213	-320	-1,154	-667	-383	-887
Net Cash From Continuing Investing Activities	-104	-204	-213	-320	-1,154	-667	-383	-887
Purchase of Property, Plant & Equipment	-173	-165	-190	-215	-239	-288	-362	-360
Acquisitions	-66	-46	-13	-110	-909	-550	-43	-546
Purchase of Investments	-6.36	0.00	-4.96	0.00	-4.40	0.00	0.00	-1.50
Sale of Property, Plant & Equipment	4.85	2.09	5.57	4.16	0.57	1.74	15	7.38
Divestitures	136	8.89	2.48	0.44	0.52	170	6.62	9.46
Sale and/or Maturity of Investments	-	-	-	-	-	-	0.00	3.88
Net Cash From Financing Activities	-267	-356	-295	-163	346	116	-499	-85
Net Cash From Continuing Financing Activities	-267	-356	-295	-163	346	116	-499	-85
Repayment of Debt	-370	-213	-113	-28	-78	-924	1.83	132
Repurchase of Preferred Equity	-	-	-	-	-	-721	-91	0.00
Repurchase of Common Equity	-98	-65	-81	-51	-15	-56	-309	-12
Payment of Dividends	-103	-106	-114	-125	-140	-197	-186	-208
Issuance of Debt	-	29	13	35	577	2,010	242	0.00
Issuance of Common Equity	9.98	0.00	0.00	6.05	2.26	3.67	0.00	2.99
Effect of Exchange Rate Changes	-19	21	-12	-8.73	20	-6.29	-	-2.06

This table details how cash moves in and out of STERIS's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	6/30/2022	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	-32	-58	1.11	-51	0.26	5.14	-18	11	-8.69	-26	-17
Net Cash From Operating Activities	232	104	206	216	281	146	291	255	304	251	333
Net Cash From Continuing Operating Activities	232	104	203	211	281	146	291	255	304	255	333
Net Income / (Loss) Continuing Operations	111	-315	123	187	124	116	141	-1.00	146	151	173
Consolidated Net Income / (Loss)	111	-315	123	187	124	116	141	-1.00	146	151	173
Depreciation Expense	139	134	138	142	138	152	141	134	113	115	126
Non-Cash Adjustments To Reconcile Net Income	22	502	4.80	-2.64	14	18	20	249	0.20	35	7.90
Changes in Operating Assets and Liabilities, net	-40	-220	-61	-116	5.75	-140	-15	-128	45	-47	26
Net Cash From Investing Activities	-109	-98	-98	-78	-67	-606	-119	-96	688	-105	-124
Net Cash From Continuing Investing Activities	-109	-98	-98	-78	-67	-606	-119	-96	688	-105	-124
Purchase of Property, Plant & Equipment	-116	-83	-92	-71	-67	-83	-119	-91	-108	-102	-89
Acquisitions	0.00	-15	-19	-8.55	0.00	-540	-	-6.50	-14	-3.81	-36
Sale of Property, Plant & Equipment	1.29	0.04	11	2.42	0.01	7.36	0.02	0.01	0.00	-	0.00
Divestitures	5.23	-	1.40	-	0.00	9.46	-	-	810	0.35	1.52
Net Cash From Financing Activities	-141	-45	-120	-192	-214	470	-198	-144	-999	-181	-214
Net Cash From Continuing Financing Activities	-141	-45	-120	-192	-214	470	-198	-144	-999	-181	-214
Repayment of Debt	-75	-51	-15	142	-14	-14	248	173	-891	-92	282
Repurchase of Common Equity	-25	-45	-84	-155	-8.72	-0.49	-2.23	-0.33	-64	-46	-100
Payment of Dividends	-43	-47	-48	-48	-47	-51	-59	-51	-52	-56	-58
Issuance of Debt	1.22	98	117	25	-145	536	-387	-266	5.59	14	-338
Effect of Exchange Rate Changes	-13	-	-	-	-0.64	-4.93	7.50	-	-1.33	9.46	-12

This table presents STERIS's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2018	2019	2020	2021	2022	2023	2024
Period end date	3/31/2018	3/31/2019	3/31/2020	3/31/2021	3/31/2022	3/31/2023	3/31/2024
Total Assets	5,200	5,073	5,441	6,574	11,424	10,822	11,064
Total Current Assets	990	1,054	1,224	1,212	1,879	2,011	2,869
Cash & Equivalents	202	221	320	221	348	208	207
Accounts Receivable	528	555	586	609	799	865	1,008
Inventories, net	206	208	264	315	575	604	675
Prepaid Expenses	54	60	54	67	157	176	174
Other Current Nonoperating Assets	-	-	-	-	-	158	805
Plant, Property, & Equipment, net	1,011	1,032	1,112	1,235	1,553	1,633	1,765
Total Noncurrent Assets	3,200	2,988	3,105	4,127	7,992	7,178	6,429
Goodwill	2,434	2,323	2,356	3,026	4,404	3,879	4,071
Intangible Assets	727	605	565	898	3,329	2,077	2,119
Other Noncurrent Operating Assets	39	60	183	203	259	244	239
Total Liabilities & Shareholders' Equity	5,200	5,073	5,441	6,574	11,424	10,822	11,064
Total Liabilities	1,983	1,887	2,023	2,683	4,879	4,735	4,748
Total Current Liabilities	398	465	504	578	922	862	931
Short-Term Debt	-	0.00	20	0.00	143	60	86
Accounts Payable	136	153	149	157	226	264	252
Accrued Expenses	168	188	192	221	307	298	320
Current Deferred & Payable Income Tax Liabilities	0.38	15	14	28	27	40	14
Current Employee Benefit Liabilities	94	109	128	150	184	118	165
Other Current Liabilities	-	-	-	23	36	30	31
Other Current Nonoperating Liabilities	-	-	-	-	-	51	64
Total Noncurrent Liabilities	1,585	1,422	1,519	2,105	3,957	3,873	3,817
Long-Term Debt	1,316	1,183	1,151	1,651	2,945	3,019	3,120
Capital Lease Obligations	-	0.00	114	130	155	140	146
Noncurrent Deferred & Payable Income Tax Liabilities	160	151	164	237	781	618	480
Other Noncurrent Operating Liabilities	109	88	90	88	76	76	72
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	3,217	3,186	3,418	3,891	6,545	6,087	6,315
Total Preferred & Common Equity	3,206	3,178	3,405	3,881	6,532	6,077	6,302
Total Common Equity	3,206	3,178	3,405	3,881	6,532	6,077	6,302
Common Stock	2,048	1,999	1,982	2,003	4,743	4,486	4,543
Retained Earnings	1,146	1,339	1,659	1,939	1,999	1,912	2,088
Accumulated Other Comprehensive Income / (Loss)	12	-160	-235	-61	-210	-321	-329
Noncontrolling Interest	11	7.99	13	10	12	9.97	13

This table presents STERIS's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	6/30/2022	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Total Assets	11,188	10,490	10,800	10,822	10,784	11,281	11,435	11,064	10,109	10,242	10,008
Total Current Assets	1,848	1,888	1,977	2,011	2,031	2,174	2,219	2,869	1,940	1,938	1,898
Cash & Equivalents	316	258	259	208	209	214	196	207	198	172	155
Accounts Receivable	764	780	823	865	888	940	964	1,008	893	923	915
Inventories, net	620	645	694	604	769	821	856	675	699	689	650
Prepaid Expenses	147	205	200	176	166	199	204	174	151	153	178
Other Current Nonoperating Assets	-	-	-	158	-	-	-	805	0.00	0.00	0.00
Plant, Property, & Equipment, net	1,573	1,572	1,671	1,633	1,726	1,744	1,844	1,765	1,834	1,930	1,922
Total Noncurrent Assets	7,767	7,029	7,152	7,178	7,027	7,363	7,372	6,429	6,334	6,375	6,189
Goodwill	4,321	3,705	3,853	3,879	3,887	4,040	4,112	4,071	4,057	4,151	4,044
Intangible Assets	3,193	3,077	3,031	2,077	2,865	3,058	2,987	2,119	2,049	2,004	1,923
Other Noncurrent Operating Assets	253	246	268	244	275	265	273	239	228	220	222
Total Liabilities & Shareholders' Equity	11,188	10,490	10,800	10,822	10,784	11,281	11,435	11,064	10,109	10,242	10,008
Total Liabilities	4,769	4,676	4,751	4,735	4,606	5,091	5,007	4,748	3,738	3,632	3,580
Total Current Liabilities	908	873	796	862	887	873	914	931	834	805	891
Short-Term Debt	151	151	60	60	63	71	78	86	80	80	125
Accounts Payable	229	233	242	264	261	294	277	252	232	235	238
Accrued Expenses	318	304	303	298	333	307	318	320	287	307	335
Current Deferred & Payable Income Tax Liabilities	38	17	25	40	64	32	25	14	57	5.85	0.00
Current Employee Benefit Liabilities	138	134	131	118	132	136	179	165	149	147	161
Other Current Liabilities	36	34	35	30	34	34	37	31	30	31	32
Other Current Nonoperating Liabilities	-	-	-	51	-	-	-	64	0.00	0.00	0.00
Total Noncurrent Liabilities	3,861	3,803	3,955	3,873	3,719	4,218	4,093	3,817	2,904	2,826	2,689
Long-Term Debt	2,846	2,874	3,002	3,019	2,860	3,366	3,231	3,120	2,236	2,156	2,039
Capital Lease Obligations	150	143	156	140	165	162	163	146	139	133	124
Noncurrent Deferred & Payable Income Tax Liabilities	791	710	725	618	618	613	621	480	456	463	453
Other Noncurrent Operating Liabilities	73	76	73	76	77	77	78	72	72	74	73
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	6,419	5,813	6,049	6,087	6,178	6,189	6,428	6,315	6,370	6,610	6,429
Total Preferred & Common Equity	6,408	5,802	6,038	6,077	6,168	6,178	6,415	6,302	6,355	6,593	6,416
Total Common Equity	6,408	5,802	6,038	6,077	6,168	6,178	6,415	6,302	6,355	6,593	6,416
Common Stock	4,739	4,705	4,632	4,486	4,498	4,519	4,534	4,543	4,500	4,491	4,405
Retained Earnings	2,057	1,695	1,771	1,912	1,981	2,046	2,134	2,088	2,178	2,268	2,386
Accumulated Other Comprehensive Income / (Loss)	-388	-598	-364	-321	-311	-387	-253	-329	-323	-166	-374
Noncontrolling Interest	12	11	10	9.97	10	11	13	13	16	17	12

This table displays calculated financial ratios and metrics derived from STERIS's official financial filings.

Metric	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	3/31/2017	3/31/2018	3/31/2019	3/31/2020	3/31/2021	3/31/2022	3/31/2023	3/31/2024
Growth Metrics	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	0.28%	6.19%	8.94%	2.53%	35.91%	7.41%	13.28%
EBITDA Growth	0.00%	39.93%	9.59%	15.05%	5.12%	39.03%	24.63%	5.68%
EBIT Growth	0.00%	76.99%	2.08%	30.19%	2.91%	-17.74%	72.74%	7.48%
NOPAT Growth	0.00%	142.39%	3.32%	29.39%	-4.25%	-11.88%	74.56%	1.76%
Net Income Growth	0.00%	163.60%	4.50%	33.84%	-2.69%	-38.80%	-56.43%	259.20%
EPS Growth	0.00%	164.84%	4.72%	34.08%	-2.73%	-46.44%	-56.85%	256.07%
Operating Cash Flow Growth	0.00%	7.91%	17.89%	9.46%	16.78%	-0.70%	10.53%	28.58%
Free Cash Flow Firm Growth	0.00%	0.00%	113.30%	-63.41%	-432.34%	-458.72%	156.74%	-101.33%
Invested Capital Growth	0.00%	0.00%	-4.46%	5.90%	24.37%	73.17%	-14.89%	8.53%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	1.84%	1.65%	-0.58%	-5.17%	-4.97%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	1.99%	-0.48%	16.75%	72.53%	1.64%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	2.61%	-2.09%	-0.09%	493.45%	3.14%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	3.97%	-8.50%	5.78%	656.23%	-3.12%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	3.75%	-8.43%	-12.50%	463.64%	-33.09%
EPS Q/Q Growth	0.00%	0.00%	0.00%	3.70%	-8.13%	-14.19%	635.00%	-33.28%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	3.56%	-1.62%	-2.30%	6.18%	4.18%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	-12.85%	6.91%	239.73%	-46.17%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	-1.66%	-0.72%	-2.96%	-10.80%	-10.15%
Profitability Metrics	-	-	-	-	-	-	-	-
Gross Margin	39.28%	41.71%	42.23%	43.55%	43.22%	44.59%	43.66%	43.17%
EBITDA Margin	15.97%	22.29%	23.00%	24.29%	24.91%	25.48%	29.56%	27.58%
Operating Margin	8.66%	15.26%	14.77%	17.72%	17.65%	11.31%	17.44%	16.27%
EBIT Margin	8.77%	15.48%	14.88%	17.78%	17.85%	10.80%	17.38%	16.49%
Profit (Net Income) Margin	4.23%	11.13%	10.95%	13.46%	12.77%	5.75%	2.33%	7.40%
Tax Burden Percent	59.92%	82.15%	82.58%	81.78%	76.69%	66.21%	15.55%	54.08%
Interest Burden Percent	80.57%	87.52%	89.13%	92.53%	93.30%	80.39%	86.30%	82.96%
Effective Tax Rate	40.08%	17.85%	17.42%	18.22%	23.32%	22.45%	18.24%	21.28%
Return on Invested Capital (ROIC)	0.00%	15.17%	8.01%	10.31%	8.55%	4.98%	7.40%	7.86%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	8.55%	4.66%	7.04%	6.68%	-0.76%	-14.94%	-4.93%
Return on Net Nonoperating Assets (RNNOA)	0.00%	2.96%	1.50%	2.04%	2.31%	-0.32%	-5.73%	-1.73%
Return on Equity (ROE)	0.00%	18.13%	9.52%	12.35%	10.86%	4.65%	1.68%	6.13%
Cash Return on Invested Capital (CROIC)	0.00%	-184.83%	12.57%	4.57%	-13.17%	-48.59%	23.50%	-0.33%
Operating Return on Assets (OROA)	0.00%	7.80%	8.06%	10.25%	9.23%	5.07%	7.09%	7.74%
Return on Assets (ROA)	0.00%	5.61%	5.93%	7.76%	6.61%	2.70%	0.95%	3.47%
Return on Common Equity (ROCE)	0.00%	18.06%	9.49%	12.31%	10.82%	4.64%	1.67%	6.12%
Return on Equity Simple (ROE_SIMPLE)	0.00%	9.10%	9.59%	11.98%	10.23%	3.72%	1.74%	6.03%
Net Operating Profit after Tax (NOPAT)	136	329	339	439	421	371	647	658
NOPAT Margin	5.19%	12.54%	12.20%	14.49%	13.53%	8.77%	14.26%	12.81%
Net Nonoperating Expense Percent (NNEP)	0.00%	6.62%	3.35%	3.27%	1.87%	5.73%	22.35%	12.79%
Cost of Revenue to Revenue	60.72%	58.29%	57.77%	56.45%	56.78%	55.41%	56.34%	56.83%
SG&A Expenses to Revenue	26.10%	24.12%	24.08%	23.65%	23.53%	31.22%	24.04%	24.37%
R&D to Revenue	2.27%	2.32%	2.27%	2.16%	2.13%	2.05%	2.17%	2.02%
Operating Expenses to Revenue	30.62%	26.45%	27.46%	25.83%	25.57%	33.27%	26.22%	26.89%
Earnings before Interest and Taxes (EBIT)	229	406	414	539	555	456	788	847
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	417	584	640	736	774	1,076	1,341	1,417
Valuation Ratios	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	3.37	4.09	3.64	3.10	3.53
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	23.72	0.00	0.00	155.13	198.05
Price to Revenue (P/Rev)	0.00	0.00	0.00	3.79	5.10	5.62	4.15	4.32
Price to Earnings (P/E)	0.00	0.00	0.00	28.15	39.92	97.39	175.79	58.73
Dividend Yield	1.68%	1.38%	1.08%	1.07%	0.84%	0.71%	0.97%	0.90%
Earnings Yield	0.00%	0.00%	0.00%	3.55%	2.51%	1.03%	0.57%	1.70%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	2.84	3.20	2.82	2.72	2.91
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	4.11	5.61	6.31	4.81	4.94
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	16.92	22.52	24.77	16.28	17.90
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	23.10	31.43	58.42	27.70	29.95
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	28.36	41.46	71.94	33.76	38.55
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	21.09	25.28	38.93	28.85	26.07
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	63.92	0.00	0.00	10.64	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.41	0.37	0.38	0.46	0.50	0.53	0.53
Long-Term Debt to Equity	0.00	0.41	0.37	0.37	0.46	0.47	0.52	0.52
Financial Leverage	0.00	0.35	0.32	0.29	0.35	0.43	0.38	0.35
Leverage Ratio	0.00	1.62	1.60	1.59	1.64	1.72	1.76	1.76
Compound Leverage Factor	0.00	1.41	1.43	1.47	1.53	1.39	1.52	1.46
Debt to Total Capital	0.00%	29.03%	27.08%	27.31%	31.39%	33.14%	34.58%	34.67%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.42%	0.00%	1.46%	0.64%	0.89%
Long-Term Debt to Total Capital	0.00%	29.03%	27.08%	26.89%	31.39%	31.68%	33.94%	33.78%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.25%	0.18%	0.27%	0.18%	0.13%	0.11%	0.14%
Common Equity to Total Capital	0.00%	70.72%	72.74%	72.41%	68.43%	66.74%	65.31%	65.19%
Debt to EBITDA	0.00	2.25	1.85	1.74	2.30	3.01	2.40	2.37
Net Debt to EBITDA	0.00	1.91	1.50	1.31	2.02	2.69	2.24	2.22
Long-Term Debt to EBITDA	0.00	2.25	1.85	1.72	2.30	2.88	2.35	2.30
Debt to NOPAT	0.00	4.01	3.49	2.92	4.23	8.75	4.98	5.09
Net Debt to NOPAT	0.00	3.39	2.84	2.20	3.71	7.81	4.65	4.78
Long-Term Debt to NOPAT	0.00	4.01	3.49	2.88	4.23	8.37	4.88	4.96
Altman Z-Score	0.00	0.00	0.00	4.87	4.83	3.77	3.42	4.00
Noncontrolling Interest Sharing Ratio	0.00%	0.35%	0.30%	0.32%	0.32%	0.22%	0.18%	0.19%
Liquidity Ratios	-	-	-	-	-	-	-	-
Current Ratio	0.00	2.48	2.27	2.43	2.10	2.04	2.33	3.08
Quick Ratio	0.00	1.83	1.67	1.80	1.44	1.24	1.25	1.31
Cash Flow Metrics	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-4,003	532	195	-648	-3,618	2,053	-27
Operating Cash Flow to CapEx	252.35%	280.13%	292.97%	280.74%	288.92%	239.59%	217.90%	275.76%
Free Cash Flow to Firm to Interest Expense	0.00	-79.07	11.83	4.84	-17.42	-40.43	19.02	-0.19
Operating Cash Flow to Interest Expense	9.53	9.04	11.99	14.66	18.55	7.65	7.01	6.74
Operating Cash Flow Less CapEx to Interest Expense	5.75	5.81	7.89	9.44	12.13	4.46	3.79	4.30
Efficiency Ratios	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.50	0.54	0.58	0.52	0.47	0.41	0.47
Accounts Receivable Turnover	0.00	4.96	5.14	5.31	5.20	6.00	5.45	5.49
Inventory Turnover	0.00	7.42	7.76	7.25	6.10	5.26	4.33	4.57
Fixed Asset Turnover	0.00	2.59	2.72	2.83	2.65	3.03	2.85	3.02
Accounts Payable Turnover	0.00	11.24	11.13	11.32	11.52	12.23	10.43	11.32
Days Sales Outstanding (DSO)	0.00	73.57	71.06	68.74	70.23	60.86	66.95	66.53
Days Inventory Outstanding (DIO)	0.00	49.17	47.01	50.33	59.85	69.41	84.23	79.92
Days Payable Outstanding (DPO)	0.00	32.47	32.79	32.24	31.68	29.84	34.99	32.24
Cash Conversion Cycle (CCC)	0.00	90.26	85.27	86.83	98.40	100.43	116.19	114.21
Capital & Investment Metrics	-	-	-	-	-	-	-	-
Invested Capital	0.00	4,332	4,139	4,383	5,451	9,440	8,034	8,719
Invested Capital Turnover	0.00	1.21	0.66	0.71	0.63	0.57	0.52	0.61
Increase / (Decrease) in Invested Capital	0.00	4,332	-193	244	1,068	3,989	-1,406	686
Enterprise Value (EV)	0.00	0.00	0.00	12,454	17,433	26,659	21,834	25,373
Market Capitalization	0.00	0.00	0.00	11,476	15,863	23,751	18,814	22,215
Book Value per Share	$0.00	$0.00	$37.59	$40.15	$45.47	$65.24	$61.21	$63.78
Tangible Book Value per Share	$0.00	$0.00	$2.96	$5.70	($0.51)	($11.99)	$1.22	$1.14
Total Capital	0.00	4,533	4,369	4,703	5,672	9,788	9,305	9,667
Total Debt	0.00	1,316	1,183	1,284	1,780	3,243	3,218	3,352
Total Long-Term Debt	0.00	1,316	1,183	1,265	1,780	3,101	3,158	3,266
Net Debt	0.00	1,114	963	965	1,560	2,895	3,010	3,145
Capital Expenditures (CapEx)	168	163	184	210	239	286	347	353
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	390	368	421	413	751	1,001	1,817
Debt-free Net Working Capital (DFNWC)	0.00	591	589	740	634	1,100	1,210	2,024
Net Working Capital (NWC)	0.00	591	589	720	634	957	1,150	1,938
Net Nonoperating Expense (NNE)	25	37	35	31	24	128	541	278
Net Nonoperating Obligations (NNO)	0.00	1,114	953	965	1,560	2,895	1,947	2,404
Total Depreciation and Amortization (D&A)	188	178	226	197	219	620	553	570
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	14.87%	13.22%	13.88%	13.30%	17.79%	22.07%	35.36%
Debt-free Net Working Capital to Revenue	0.00%	22.56%	21.15%	24.42%	20.40%	26.04%	26.67%	39.39%
Net Working Capital to Revenue	0.00%	22.56%	21.15%	23.77%	20.40%	22.65%	25.34%	37.71%
Earnings Adjustments	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$3.59	$4.81	$4.66	$2.50	$1.07	$3.83
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	84.54M	84.92M	170.74M	200.16M	197.30M	197.80M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$3.56	$4.76	$4.63	$2.48	$1.07	$3.81
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	84.54M	84.92M	170.74M	200.16M	197.30M	197.80M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	84.54M	84.92M	170.74M	200.16M	197.30M	197.80M
Normalized Net Operating Profit after Tax (NOPAT)	171	329	365	440	418	371	647	679
Normalized NOPAT Margin	6.53%	12.54%	13.12%	14.51%	13.46%	8.77%	14.27%	13.21%
Pre Tax Income Margin	7.07%	13.55%	13.26%	16.46%	16.65%	8.69%	15.00%	13.68%
Debt Service Ratios	-	-	-	-	-	-	-	-
EBIT to Interest Expense	5.15	8.01	9.20	13.38	14.92	5.10	7.30	5.87
NOPAT to Interest Expense	3.04	6.49	7.54	10.90	11.31	4.14	5.99	4.56
EBIT Less CapEx to Interest Expense	1.37	4.78	5.11	8.16	8.50	1.90	4.08	3.42
NOPAT Less CapEx to Interest Expense	-0.73	3.26	3.45	5.68	4.89	0.95	2.77	2.11
Payout Ratios	-	-	-	-	-	-	-	-
Dividend Payout Ratio	93.20%	36.48%	37.44%	30.62%	35.38%	81.05%	175.56%	54.82%
Augmented Payout Ratio	181.34%	58.94%	64.18%	43.19%	39.07%	104.02%	467.17%	57.92%

This table displays calculated financial ratios and metrics derived from STERIS's official financial filings.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	6/30/2022	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	19.42%	0.30%	0.58%	13.46%	2.33%	3.14%	6.72%	15.87%	8.12%	7.33%	5.61%
EBITDA Growth	287.79%	-173.95%	0.72%	147.96%	13.69%	302.27%	12.95%	-56.66%	-5.55%	-4.41%	1.24%
EBIT Growth	2,299.93%	-372.49%	-8.03%	414.76%	26.34%	162.81%	20.99%	-66.40%	3.27%	11.29%	8.44%
NOPAT Growth	1,196.48%	-336.95%	-7.81%	509.41%	19.11%	169.22%	20.95%	-70.49%	-4.32%	14.93%	4.73%
Net Income Growth	605.68%	-552.76%	-13.82%	259.18%	11.77%	136.91%	14.29%	-100.54%	17.57%	29.93%	22.95%
EPS Growth	558.33%	-556.52%	-12.68%	208.20%	13.64%	136.83%	14.52%	-101.06%	16.80%	30.17%	23.24%
Operating Cash Flow Growth	137.87%	-39.40%	-15.86%	25.66%	21.31%	40.71%	41.67%	18.08%	8.04%	71.62%	14.28%
Free Cash Flow Firm Growth	110.23%	116.62%	121.27%	153.36%	-34.81%	-184.60%	-160.03%	-123.65%	66.78%	233.46%	355.44%
Invested Capital Growth	-4.17%	-10.70%	-7.41%	-14.89%	-2.08%	9.76%	7.75%	8.53%	-4.76%	-8.01%	-11.79%
Revenue Q/Q Growth	-4.48%	3.81%	1.29%	-20.78%	22.85%	4.63%	4.81%	-20.03%	14.63%	3.86%	3.13%
EBITDA Q/Q Growth	-3.45%	-157.53%	291.61%	172.56%	-62.16%	2.37%	7.00%	6.19%	-17.55%	3.60%	13.32%
EBIT Q/Q Growth	69.06%	-294.73%	161.54%	296.32%	-73.40%	-3.19%	18.55%	15.27%	-18.25%	4.34%	15.51%
NOPAT Q/Q Growth	94.29%	-265.00%	168.42%	352.60%	-76.69%	-4.11%	19.55%	15.34%	-24.41%	15.17%	8.95%
Net Income Q/Q Growth	112.77%	-384.62%	139.12%	51.60%	-33.79%	-6.01%	21.14%	-100.71%	14,625.05%	3.87%	14.63%
EPS Q/Q Growth	80.33%	-386.36%	139.37%	51.61%	-33.51%	-7.20%	22.41%	-101.41%	7,400.00%	3.42%	15.89%
Operating Cash Flow Q/Q Growth	34.95%	-55.20%	98.01%	4.97%	30.27%	-48.03%	99.35%	-12.51%	19.21%	-17.45%	32.75%
Free Cash Flow Firm Q/Q Growth	113.58%	55.93%	4.42%	138.70%	-83.23%	-302.36%	25.90%	7.31%	218.29%	61.93%	41.82%
Invested Capital Q/Q Growth	-2.01%	-5.70%	3.25%	-10.80%	12.75%	5.70%	1.36%	-10.15%	-1.06%	2.09%	-2.80%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	44.77%	44.34%	42.89%	42.47%	44.70%	44.11%	43.15%	40.19%	44.74%	43.55%	44.53%
EBITDA Margin	25.64%	-14.21%	26.88%	92.48%	28.48%	27.87%	28.45%	34.59%	24.88%	24.82%	27.27%
Operating Margin	13.70%	-25.52%	15.69%	77.69%	16.71%	15.47%	17.45%	21.97%	14.50%	16.53%	17.90%
EBIT Margin	13.63%	-25.57%	15.53%	77.72%	16.83%	15.57%	17.61%	22.54%	16.07%	16.15%	18.08%
Profit (Net Income) Margin	9.58%	-26.26%	10.14%	19.41%	10.46%	9.40%	10.86%	-0.09%	11.37%	11.38%	12.64%
Tax Burden Percent	82.07%	94.65%	76.92%	26.04%	74.22%	74.65%	74.34%	-0.47%	83.04%	77.57%	75.75%
Interest Burden Percent	85.62%	108.51%	84.88%	95.91%	83.75%	80.84%	82.96%	85.65%	85.22%	90.83%	92.30%
Effective Tax Rate	17.93%	0.00%	23.08%	11.24%	21.71%	22.49%	21.62%	20.08%	20.15%	22.32%	24.21%
Return on Invested Capital (ROIC)	5.68%	-9.23%	6.16%	35.80%	6.52%	6.03%	6.85%	10.77%	6.85%	7.44%	8.02%
ROIC Less NNEP Spread (ROIC-NNEP)	5.02%	-12.51%	5.39%	16.09%	5.43%	5.01%	5.67%	1.72%	6.75%	6.74%	7.55%
Return on Net Nonoperating Assets (RNNOA)	2.28%	-6.21%	2.58%	6.17%	2.46%	2.63%	2.84%	0.60%	2.76%	2.94%	3.18%
Return on Equity (ROE)	7.96%	-15.44%	8.74%	41.97%	8.99%	8.66%	9.68%	11.37%	9.62%	10.38%	11.19%
Cash Return on Invested Capital (CROIC)	8.99%	11.04%	6.45%	23.50%	9.44%	2.93%	4.83%	-0.33%	12.24%	15.68%	19.99%
Operating Return on Assets (OROA)	5.59%	-10.98%	6.61%	31.70%	6.99%	6.58%	7.42%	10.58%	8.05%	7.99%	9.10%
Return on Assets (ROA)	3.93%	-11.28%	4.31%	7.92%	4.34%	3.97%	4.57%	-0.04%	5.70%	5.63%	6.37%
Return on Common Equity (ROCE)	7.94%	-15.42%	8.73%	41.90%	8.97%	8.64%	9.66%	11.35%	9.60%	10.36%	11.17%
Return on Equity Simple (ROE_SIMPLE)	5.86%	-0.16%	-0.48%	0.00%	1.93%	8.91%	8.85%	0.00%	6.32%	6.62%	7.31%
Net Operating Profit after Tax (NOPAT)	130	-214	147	664	155	148	177	196	148	171	186
NOPAT Margin	11.24%	-17.87%	12.07%	68.96%	13.08%	11.99%	13.68%	17.56%	11.58%	12.84%	13.56%
Net Nonoperating Expense Percent (NNEP)	0.65%	3.28%	0.77%	19.71%	1.09%	1.02%	1.17%	9.06%	0.10%	0.70%	0.47%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	1.79%	-	-	-	2.13%
Cost of Revenue to Revenue	55.23%	55.66%	57.11%	57.53%	55.30%	55.89%	56.85%	59.81%	55.26%	56.45%	55.47%
SG&A Expenses to Revenue	28.93%	26.92%	25.09%	13.26%	25.90%	26.52%	23.76%	13.63%	26.23%	24.78%	24.48%
R&D to Revenue	2.14%	2.08%	2.10%	2.42%	2.09%	2.12%	1.95%	2.26%	2.00%	2.03%	2.00%
Operating Expenses to Revenue	31.08%	69.87%	27.20%	-35.22%	27.99%	28.64%	25.70%	18.22%	30.24%	27.02%	26.63%
Earnings before Interest and Taxes (EBIT)	158	-307	189	749	199	193	229	252	206	215	248
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	296	-171	327	891	337	345	369	386	318	330	374
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.17	2.83	3.02	3.10	3.56	3.48	3.35	3.53	3.42	3.63	3.16
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	155.13	0.00	0.00	0.00	198.05	87.25	54.56	45.20
Price to Revenue (P/Rev)	4.26	3.44	3.82	4.15	4.82	4.67	4.59	4.32	4.15	4.49	3.76
Price to Earnings (P/E)	53.92	0.00	0.00	175.79	184.26	39.04	37.96	58.73	54.27	55.01	43.39
Dividend Yield	0.85%	1.07%	0.98%	0.97%	0.84%	0.89%	0.91%	0.90%	0.95%	0.88%	1.06%
Earnings Yield	1.85%	0.00%	0.00%	0.57%	0.54%	2.56%	2.63%	1.70%	1.84%	1.82%	2.30%
Enterprise Value to Invested Capital (EV/IC)	2.50	2.22	2.36	2.72	2.75	2.60	2.56	2.91	2.78	2.97	2.62
Enterprise Value to Revenue (EV/Rev)	4.85	4.05	4.44	4.81	5.45	5.40	5.30	4.94	4.58	4.91	4.16
Enterprise Value to EBITDA (EV/EBITDA)	19.68	25.54	27.31	16.28	18.00	13.09	12.77	17.90	17.21	18.96	16.22
Enterprise Value to EBIT (EV/EBIT)	40.73	129.57	159.82	27.70	29.98	18.70	18.12	29.95	28.10	29.85	25.07
Enterprise Value to NOPAT (EV/NOPAT)	51.82	0.00	0.00	33.76	37.03	22.21	21.57	38.55	36.80	38.79	32.91
Enterprise Value to Operating Cash Flow (EV/OCF)	28.29	25.74	29.78	28.85	30.85	29.30	26.55	26.07	24.08	23.75	19.64
Enterprise Value to Free Cash Flow (EV/FCFF)	27.26	18.96	35.13	10.64	28.79	92.68	54.87	0.00	22.15	18.14	12.29
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.49	0.55	0.53	0.53	0.50	0.58	0.54	0.53	0.39	0.36	0.36
Long-Term Debt to Equity	0.47	0.52	0.52	0.52	0.49	0.57	0.53	0.52	0.37	0.35	0.34
Financial Leverage	0.45	0.50	0.48	0.38	0.45	0.52	0.50	0.35	0.41	0.44	0.42
Leverage Ratio	1.79	1.80	1.77	1.76	1.74	1.81	1.78	1.76	1.66	1.68	1.67
Compound Leverage Factor	1.53	1.95	1.51	1.69	1.46	1.47	1.48	1.51	1.42	1.53	1.54
Debt to Total Capital	32.90%	35.28%	34.72%	34.58%	33.33%	36.77%	35.07%	34.67%	27.82%	26.38%	26.24%
Short-Term Debt to Total Capital	1.58%	1.68%	0.65%	0.64%	0.68%	0.72%	0.79%	0.89%	0.91%	0.89%	1.43%
Long-Term Debt to Total Capital	31.32%	33.59%	34.08%	33.94%	32.64%	36.05%	34.28%	33.78%	26.91%	25.49%	24.81%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.12%	0.13%	0.11%	0.11%	0.11%	0.11%	0.13%	0.14%	0.18%	0.19%	0.14%
Common Equity to Total Capital	66.98%	64.60%	65.17%	65.31%	66.56%	63.12%	64.80%	65.19%	72.00%	73.43%	73.61%
Debt to EBITDA	2.67	4.18	4.14	2.40	2.24	1.89	1.79	2.37	1.76	1.72	1.65
Net Debt to EBITDA	2.41	3.84	3.81	2.24	2.08	1.78	1.69	2.22	1.62	1.59	1.54
Long-Term Debt to EBITDA	2.55	3.98	4.06	2.35	2.19	1.86	1.75	2.30	1.70	1.66	1.56
Debt to NOPAT	7.04	-129.03	-27.67	4.98	4.60	3.22	3.02	5.09	3.77	3.52	3.36
Net Debt to NOPAT	6.33	-118.52	-25.44	4.65	4.29	3.02	2.85	4.78	3.46	3.26	3.13
Long-Term Debt to NOPAT	6.70	-122.88	-27.15	4.88	4.50	3.15	2.95	4.96	3.64	3.40	3.17
Altman Z-Score	3.39	2.81	3.17	3.41	3.73	3.39	3.45	3.82	4.50	4.98	4.48
Noncontrolling Interest Sharing Ratio	0.17%	0.17%	0.18%	0.18%	0.17%	0.19%	0.18%	0.19%	0.21%	0.22%	0.20%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.03	2.16	2.48	2.33	2.29	2.49	2.43	3.08	2.33	2.41	2.13
Quick Ratio	1.19	1.19	1.36	1.25	1.24	1.32	1.27	1.31	1.31	1.36	1.20
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	533	831	867	2,070	347	-703	-521	-490	579	938	1,330
Operating Cash Flow to CapEx	202.14%	125.49%	253.87%	312.63%	422.14%	192.39%	244.90%	278.51%	281.03%	246.07%	373.02%
Free Cash Flow to Firm to Interest Expense	23.49	31.80	30.37	67.65	10.73	-19.02	-13.37	-13.56	19.06	47.68	69.65
Operating Cash Flow to Interest Expense	10.22	3.97	7.20	7.05	8.69	3.96	7.48	7.06	10.00	12.75	17.43
Operating Cash Flow Less CapEx to Interest Expense	5.16	0.81	4.36	4.80	6.63	1.90	4.42	4.52	6.44	7.57	12.76
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.41	0.43	0.43	0.41	0.42	0.42	0.42	0.47	0.50	0.49	0.50
Accounts Receivable Turnover	6.33	6.19	6.07	5.45	5.53	5.35	5.24	5.49	5.88	5.72	5.75
Inventory Turnover	4.39	4.33	4.10	4.33	3.70	3.54	3.40	4.57	4.05	4.01	4.06
Fixed Asset Turnover	3.11	3.10	3.00	2.85	2.77	2.77	2.66	3.02	2.94	2.90	2.87
Accounts Payable Turnover	11.56	11.56	11.74	10.43	10.50	9.85	10.16	11.32	12.08	11.47	11.86
Days Sales Outstanding (DSO)	57.63	58.92	60.08	66.95	66.05	68.24	69.64	66.53	62.07	63.87	63.53
Days Inventory Outstanding (DIO)	83.09	84.35	89.09	84.23	98.61	103.10	107.22	79.92	90.07	90.91	89.95
Days Payable Outstanding (DPO)	31.58	31.56	31.08	34.99	34.76	37.06	35.92	32.24	30.22	31.83	30.78
Cash Conversion Cycle (CCC)	109.14	111.71	118.09	116.19	129.90	134.29	140.94	114.21	121.92	122.95	122.70
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	9,250	8,724	9,007	8,034	9,058	9,575	9,705	8,719	8,627	8,808	8,561
Invested Capital Turnover	0.51	0.52	0.51	0.52	0.50	0.50	0.50	0.61	0.59	0.58	0.59
Increase / (Decrease) in Invested Capital	-403	-1,045	-721	-1,406	-192	851	698	686	-431	-767	-1,144
Enterprise Value (EV)	23,170	19,345	21,227	21,834	24,876	24,866	24,804	25,373	23,985	26,133	22,435
Market Capitalization	20,327	16,424	18,259	18,814	21,987	21,469	21,515	22,215	21,713	23,919	20,290
Book Value per Share	$64.02	$58.01	$60.49	$61.21	$62.53	$62.54	$64.93	$63.78	$64.25	$66.86	$65.00
Tangible Book Value per Share	($11.06)	($9.80)	($8.48)	$1.22	($5.91)	($9.31)	($6.92)	$1.14	$2.52	$4.45	$4.55
Total Capital	9,567	8,982	9,266	9,305	9,267	9,788	9,900	9,667	8,825	8,980	8,716
Total Debt	3,148	3,168	3,218	3,218	3,088	3,599	3,472	3,352	2,455	2,369	2,287
Total Long-Term Debt	2,997	3,017	3,158	3,158	3,025	3,528	3,394	3,266	2,375	2,289	2,162
Net Debt	2,831	2,910	2,958	3,010	2,880	3,386	3,277	3,145	2,257	2,197	2,132
Capital Expenditures (CapEx)	115	83	81	69	67	76	119	91	108	102	89
Debt-free, Cash-free Net Working Capital (DFCFNWC)	774	908	981	1,001	999	1,158	1,188	1,817	988	1,040	977
Debt-free Net Working Capital (DFNWC)	1,091	1,166	1,240	1,210	1,208	1,372	1,384	2,024	1,186	1,212	1,132
Net Working Capital (NWC)	940	1,015	1,180	1,150	1,144	1,301	1,305	1,938	1,106	1,132	1,007
Net Nonoperating Expense (NNE)	19	101	23	477	31	32	37	197	2.61	19	13
Net Nonoperating Obligations (NNO)	2,831	2,910	2,958	1,947	2,880	3,386	3,277	2,404	2,257	2,197	2,132
Total Depreciation and Amortization (D&A)	139	136	138	142	138	152	141	135	113	115	126
Debt-free, Cash-free Net Working Capital to Revenue	16.22%	19.01%	20.50%	22.07%	21.90%	25.17%	25.37%	35.36%	18.87%	19.53%	18.09%
Debt-free Net Working Capital to Revenue	22.85%	24.42%	25.93%	26.67%	26.47%	29.82%	29.55%	39.39%	22.66%	22.77%	20.96%
Net Working Capital to Revenue	19.69%	21.26%	24.67%	25.34%	25.08%	28.27%	27.87%	37.71%	21.13%	21.26%	18.65%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.11	($3.15)	$1.24	$1.87	$1.25	$1.17	$1.42	($0.01)	$1.47	$1.52	$1.76
Adjusted Weighted Average Basic Shares Outstanding	200.03M	199.65M	198.57M	197.30M	197.56M	197.60M	197.63M	197.80M	197.23M	98.71M	98.25M
Adjusted Diluted Earnings per Share	$1.10	($3.15)	$1.24	$1.88	$1.25	$1.16	$1.42	($0.02)	$1.46	$1.51	$1.75
Adjusted Weighted Average Diluted Shares Outstanding	200.03M	199.65M	198.57M	197.30M	197.56M	197.60M	197.63M	197.80M	197.23M	98.71M	98.25M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	200.03M	199.65M	198.57M	197.30M	197.56M	197.60M	197.63M	197.80M	197.23M	98.71M	98.25M
Normalized Net Operating Profit after Tax (NOPAT)	130	129	147	665	155	148	178	217	169	173	188
Normalized NOPAT Margin	11.24%	10.74%	12.07%	68.99%	13.09%	11.99%	13.68%	19.42%	13.18%	13.00%	13.69%
Pre Tax Income Margin	11.67%	-27.74%	13.19%	74.54%	14.09%	12.59%	14.61%	19.30%	13.70%	14.67%	16.69%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	6.95	-11.75	6.61	24.47	6.15	5.22	5.87	6.97	6.77	10.91	12.98
NOPAT to Interest Expense	5.73	-8.21	5.14	21.71	4.79	4.02	4.56	5.43	4.88	8.68	9.74
EBIT Less CapEx to Interest Expense	1.90	-14.92	3.78	22.21	4.10	3.16	2.81	4.43	3.21	5.73	8.31
NOPAT Less CapEx to Interest Expense	0.68	-11.38	2.30	19.45	2.73	1.96	1.50	2.89	1.32	3.49	5.06
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	48.10%	-1,968.20%	-622.55%	175.56%	159.18%	35.17%	36.03%	54.82%	53.10%	49.98%	46.31%
Augmented Payout Ratio	66.69%	-3,050.28%	-1,248.37%	467.17%	405.39%	80.20%	65.26%	57.92%	69.84%	75.90%	91.38%

Key Financial Trends

STERIS plc has shown consistent revenue growth over the past several quarters, with operating revenues increasing from approximately $849 million in Q4 2022 to over $1.37 billion in Q3 2025. This reflects a strong upward trend in sales and demand for their products and services.

Profitability has also improved markedly, with net income attributable to common shareholders growing from $52.3 million in Q4 2022 to $173.5 million in Q3 2025. Earnings per share (diluted) trended upwards from $0.61 in Q4 2022 to $1.75 in Q3 2025, indicating enhanced profitability on a per-share basis despite a relatively stable share count.

Operating margins have benefited from gross profit expansion, which rose from approximately $438 million in Q4 2022 to $610 million in Q3 2025. Operating expenses, particularly selling, general and administrative expenses, have increased but at a lower rate than revenues, supporting margin improvement.

On the balance sheet, total assets have grown from about $11.4 billion in Q4 2022 to $10 billion in Q3 2025, reflecting some fluctuations. Goodwill and intangible assets remain substantial components, suggesting significant investment in acquisitions or brand value.

Liabilities have decreased from approximately $5.1 billion in Q4 2022 to $3.6 billion in Q3 2025, with long-term debt declining notably. This deleveraging trend is positive for the company's financial health and risk profile.

Cash flow analysis shows that STERIS generates strong operating cash flows, exceeding $332 million in Q3 2025, which supports investments and financing activities. Capital expenditures remain significant, reflecting ongoing investment in property, plant, and equipment. The company has actively managed its debt, with repayments exceeding issuances in recent periods.

Consistent revenue growth over the last three years, indicating strong market demand.
Increasing net income and improving earnings per share, suggesting enhanced profitability.
Improved operating margins driven by efficient expense management relative to sales growth.
Reduction in total liabilities, especially long-term debt, indicating strengthening financial position.
Strong cash generation from operations, funding investments and debt repayment.
Stable share count with no significant dilution observed, supporting EPS growth.
Significant goodwill and intangible assets on the balance sheet, which may carry impairment risk but also reflect acquisition growth strategy.
Ongoing capital expenditures remain high, signaling investment for future growth but also capital intensity.
Some fluctuations in net income and a prior large impairment charge in Q2 2023, which affected profitability negatively in that quarter.
Negative net income reported in Q2 2023 due to impairment and restructuring impacts, highlighting episodic volatility.

Overall, STERIS demonstrates a solid upward trend in revenue and profitability, improved leverage, and strong operating cash flow generation. Investors should monitor goodwill and intangible asset valuations and capital expenditure levels for ongoing impacts. The earnings recovery after impairment charges and careful debt management bode well for the company's financial stability and growth trajectory.

08/03/25 05:34 PMAI Generated. May Contain Errors.

Frequently Asked Questions About STERIS's Financials

When does STERIS's fiscal year end?

According to the most recent income statement we have on file, STERIS's financial year ends in March. Their financial year 2024 ended on March 31, 2024.

How has STERIS's net income changed over the last 7 years?

STERIS's net income appears to be on an upward trend, with a most recent value of $380.08 million in 2024, rising from $110.63 million in 2017. The previous period was $105.81 million in 2023. See STERIS's forecast for analyst expectations on what’s next for the company.

What is STERIS's operating income?

STERIS's total operating income in 2024 was $836.12 million, based on the following breakdown:

Total Gross Profit: $2.22 billion
Total Operating Expenses: $1.38 billion

How has STERIS's revenue changed over the last 7 years?

Over the last 7 years, STERIS's total revenue changed from $2.61 billion in 2017 to $5.14 billion in 2024, a change of 96.7%.

How much debt does STERIS have?

STERIS's total liabilities were at $4.75 billion at the end of 2024, a 0.3% increase from 2023, and a 139.4% increase since 2018.

How much cash does STERIS have?

In the past 6 years, STERIS's cash and equivalents has ranged from $201.53 million in 2018 to $348.32 million in 2022, and is currently $207.02 million as of their latest financial filing in 2024.

How has STERIS's book value per share changed over the last 7 years?

Over the last 7 years, STERIS's book value per share changed from 0.00 in 2017 to 63.78 in 2024, a change of 6,377.8%.

Related Companies

This page (NYSE:STE) was last updated on 8/3/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

STERIS (STE) Financials

Key Financial Trends

Frequently Asked Questions About STERIS's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

STERIS (STE) Financials

Annual Income Statements for STERIS

Quarterly Income Statements for STERIS

Annual Cash Flow Statements for STERIS

Quarterly Cash Flow Statements for STERIS

Annual Balance Sheets for STERIS

Quarterly Balance Sheets for STERIS

Annual Metrics And Ratios for STERIS

Quarterly Metrics And Ratios for STERIS

Key Financial Trends

Frequently Asked Questions About STERIS's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools